CENTRE OSCAR LAMBRET
π«π·France
- Country
- π«π·France
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 251
- Market Cap
- -
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2009-07-29
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 120
- Registration Number
- NCT00905658
- Locations
- π«π·
Centre Oscar Lambret, Lille, France
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
- First Posted Date
- 2009-05-19
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 63
- Registration Number
- NCT00904410
- Locations
- π«π·
Centre Oscar Lambret, Lille, France
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
- First Posted Date
- 2009-05-11
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 200
- Registration Number
- NCT00896467
- Locations
- π«π·
Centre Oscar Lambret, Lille, France
π«π·Laboratoire URECA, Villeneuve d'Ascq, France
Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 44
- Registration Number
- NCT00893061
- Locations
- π«π·
Centre Paul Strauss, Strasbourg, France
π«π·Centre Eugene Marquis, Rennes, France
π«π·Centre Oscar Lambret, Lille, France
Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery
Phase 2
- Conditions
- First Posted Date
- 2009-04-03
- Last Posted Date
- 2009-12-24
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 96
- Registration Number
- NCT00874874
- Locations
- π«π·
Centre Oscar Lambret, Lille, France
PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy
Not Applicable
Completed
- Conditions
- First Posted Date
- 2008-12-16
- Last Posted Date
- 2011-05-13
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 40
- Registration Number
- NCT00809016
- Locations
- π«π·
Centre Oscar Lambret, Lille, France
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
Phase 2
Completed
- Conditions
- First Posted Date
- 2008-08-21
- Last Posted Date
- 2011-05-13
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 45
- Registration Number
- NCT00738868
- Locations
- π«π·
Centre Oscar Lambret, Lille, France
Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 60
- Registration Number
- NCT00541073
- Locations
- π«π·
Centre Oscar Lambret, Lille, France
Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 19
- Registration Number
- NCT00421096
- Locations
- π«π·
Centre Leonard de Vinci, Dechy, France
π«π·Centre Oscar Lambret, Lille, France
Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 88
- Registration Number
- NCT00420563
- Locations
- π«π·
Centre Hospitalier Regional - Dermatology, Lille, France
π«π·Centre Oscar Lambret, Lille, France
π«π·Hopital Saint Vincent, Lille, France
Β© Copyright 2024. All Rights Reserved by MedPath